Tags

Type your tag names separated by a space and hit enter

Stem cell transplantation and alemtuzumab - options for 'early reprogramming' in multiple sclerosis?
Eur J Neurol. 2020 Jun 04 [Online ahead of print]EJ

Authors+Show Affiliations

Institute of Translational Neurology and Department of Neurology, University Hospital Münster, Münster, Germany.Institute of Translational Neurology and Department of Neurology, University Hospital Münster, Münster, Germany.

Pub Type(s)

Editorial

Language

eng

PubMed ID

32498122

Citation

Pfeuffer, S, and S G. Meuth. "Stem Cell Transplantation and Alemtuzumab - Options for 'early Reprogramming' in Multiple Sclerosis?" European Journal of Neurology, 2020.
Pfeuffer S, Meuth SG. Stem cell transplantation and alemtuzumab - options for 'early reprogramming' in multiple sclerosis? Eur J Neurol. 2020.
Pfeuffer, S., & Meuth, S. G. (2020). Stem cell transplantation and alemtuzumab - options for 'early reprogramming' in multiple sclerosis? European Journal of Neurology. https://doi.org/10.1111/ene.14378
Pfeuffer S, Meuth SG. Stem Cell Transplantation and Alemtuzumab - Options for 'early Reprogramming' in Multiple Sclerosis. Eur J Neurol. 2020 Jun 4; PubMed PMID: 32498122.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Stem cell transplantation and alemtuzumab - options for 'early reprogramming' in multiple sclerosis? AU - Pfeuffer,S, AU - Meuth,S G, Y1 - 2020/06/04/ PY - 2020/05/20/received PY - 2020/05/29/accepted PY - 2020/6/5/pubmed PY - 2020/6/5/medline PY - 2020/6/5/entrez JF - European journal of neurology JO - Eur. J. Neurol. SN - 1468-1331 UR - https://www.unboundmedicine.com/medline/citation/32498122/Stem_cell_transplantation_and_alemtuzumab_-_options_for_"early_reprogramming"_in_multiple_sclerosis L2 - https://doi.org/10.1111/ene.14378 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.